Extending magnifying NBI diagnosis of intestinal metaplasia in the stomach: the white opaque substance marker
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Abstract Background and aims Intestinal metaplasia (IM) of the stomach is associated with an increased risk of differentiated gastric cancer. While it is important to diagnose IM endoscopically, it can be difficult to observe by white-light endoscopy. In magnifying endoscopy with narrow-band imaging (M-NBI) of the stomach, a light-blue crest (LBC) is widely known to be a useful marker in the endoscopic diagnosis of IM. However, IM that exhibits only white opaque substance (WOS) without an LBC can also occur. The aim of this study was to elucidate whether the presence of WOS on M-NBI of the stomach could serve as a marker of IM in the same way that an LBC does. Methods The subjects were 40 consecutive patients who underwent M-NBI between July and December 2014. The primary endpoint in this study was to evaluate the diagnostic performance of M-NBI for histologically observed IM in WOS- and LBC-positive mucosa. Results The sensitivity and specificity of WOS for histologically diagnosed IM were 50.0 % (95 % confidence interval [CI] 40.0 % – 50.0 %) and 100.0 % (95 %CI 85.0 % – 100.0 %), respectively. Meanwhile, the sensitivity and specificity of LBC were 62.5 % (95 %CI 51.1 % – 65.9 %) and 93.8 % (95 %CI 76.7 % – 98.9 %), respectively. The sensitivity and specificity of WOS and/or LBC (WOS positive and LBC positive, WOS positive and LBC negative, or WOS negative and LBC positive) for histologically diagnosed IM were 87.5 % (95 %CI 76.9 % – 90.9 %) and 93.8 % (95 %CI 77.9 % – 98.9 %), respectively. Conclusions LBC and WOS are both useful markers for endoscopic diagnosis of IM. Combining both markers improves the sensitivity. Clinical trial number: UMINCTR000014453.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“is also a useful marker for IM, with high specificity (100%; 95% confidence interval, 85%–100%) and limited sensitivity (50%; 95% confidence interval, 40%–50%) in 1 study.60”
From AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021) · cites this paper as [60]
Citations
Cites
Helicobacter pylori Infection and the Development of Gastric Cancer
Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., & Schlemper, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa001999 · Cited by 4,465
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · BMJ · doi:10.1136/bmj.326.7379.41 · Cited by 3,215
Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · Radiology · doi:10.1148/radiol.2261021292 · Cited by 3,215
An Endoscopic Recognition of the Atrophic Border and its Significance in Chronic Gastritis
Kimura, K., & Takemoto, T. (1969) · Endoscopy · doi:10.1055/s-0028-1098086 · Cited by 1,042 · cited 1×
“The progression of atrophic gastritis was evaluated according to the Kimura – Takemoto classification [17].”
MethodMagnifying endoscopy for diagnosing and delineating early gastric cancer
Yao, K., Anagnostopoulos, G., & Ragunath, K. (2009) · Endoscopy · doi:10.1055/s-0029-1214594 · Cited by 460 · cited 1×
“Furthermore, to maintain a fixed focal distance between the mucosal surface and the endoscope tip during magnifying endoscopic examinations at maximum magnification, a black soft hood (MAJ1989 for the GIF-Q240Z, MAJ1990 for the GIF-H260Z; Olympus) was mounted to the distal end of the endoscope [16].”
BackgroundSelf-citationUedo, N., Ishihara, R., Iishi, H., Yamamoto, S., Yamamoto, S., Yamada, T., Imanaka, K., Takeuchi, Y., Higashino, K., Ishiguro, S., et al. (2006) · Endoscopy · doi:10.1055/s-2006-944632 · Cited by 385 · cited 1×
“discovered a blue-white line visible on the epithelial surface of IM on magnifying endoscopy with narrow-band imaging (M-NBI) of the stomach and called it a “light-blue crest” (LBC) [5].”
BackgroundRokkas, T., Filipe, M. I., & Sladen, G. E. (1991) · Gut · doi:10.1136/gut.32.10.1110 · Cited by 253
Filipe, M. I., Potet, F., Bogomoletz, W. V., Dawson, P. A., Fabiani, B., Chauveinc, P., Fenzy, A., Gazzard, B., Goldfain, D., & Zeegen, R. (1985) · Gut · doi:10.1136/gut.26.12.1319 · Cited by 203
Yao, K., Iwashita, A., Tanabe, H., Nishimata, N., Nagahama, T., Maki, S., Takaki, Y., Hirai, F., Hisabe, T., Nishimura, T., et al. (2008) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2008.04.011 · Cited by 170 · cited 1×
“The nature, origin, and other aspects of this white substance were completely unknown, so we named this substance “white opaque substance” (WOS) [10].”
BackgroundSelf-citation
Cited by
Banks, M., Graham, D., Jansen, M., Gotoda, T., Coda, S., di Pietro, M., Uedo, N., Bhandari, P., Pritchard, D. M., Kuipers, E. J., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-318126 · Cited by 647
“In a recent study by Kanemitsu et al.(168), the sensitivity and specificity of LBC for histologically diagnosed IM were 62.”
BackgroundAGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review
Shah, S. C., Piazuelo, M. B., Kuipers, E. J., & Li, D. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.078 · Cited by 560
“The so-called white opaque fields (or “white opaque substance”) (Figure 2D), which is the result of microscopic lipid droplets that accumulate in the mucosa of gastric tumors and IM, is also a useful marker for IM, with high specificity (100%; 95% confidence interval, 85%–100%) and limited sensitivity (50%; 95% confid…”
BackgroundGuidelines for endoscopic diagnosis of early gastric cancer
Yao, K., Uedo, N., Kamada, T., Hirasawa, T., Nagahama, T., Yoshinaga, S., Oka, M., Inoue, K., Mabe, K., Yao, T., et al. (2020) · Digestive Endoscopy · doi:10.1111/den.13684 · Cited by 241
Self-citationEndoscopic Kyoto classification of Helicobacter pylori infection and gastric cancer risk diagnosis
Toyoshima, O., Nishizawa, T., & Koike, K. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i5.466 · Cited by 179
ACG Clinical Guideline: Diagnosis and Management of Gastric Premalignant Conditions
Morgan, D. R., Corral, J. E., Li, D., Montgomery, E. A., Riquelme, A. J., Kim, J. J., Sauer, B. G., & Shah, S. C. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003350 · Cited by 118
“(86), and the “ white opaque substance ” sign, which appears as nodular patches of white raised mucosa and histologically represents accumulation of lipid droplets (88).”
Metadata
- Authors
- Kanemitsu, T., Yao, K., Nagahama, T., Imamura, K., Fujiwara, S., Ueki, T., Chuman, K., Tanabe, H., Atsuko, O., Iwashita, A., Shimokawa, T., Uchita, K., & Kanesaka, T.
- Affiliations
- Fukuoka University (JP)
- Department of Pathology, Fukuoka University Chikushi Hospital, Fukuoka, Japan
- Wakayama Medical University (JP)
- Japanese Red Cross Kochi Hospital (JP)
- Osaka International Cancer Institute (JP)
- ORCID
- Venue
- Endoscopy
- Publisher
- Georg Thieme Verlag KG
- Published
- 2017-04-10
- Volume
- 49
- Issue
- 06
- Pages
- 529-535
- ISSN
- 0013-726X (ISSN-L)
- 1438-8812
- OpenAlex
- W2606521355
- Cited by
- 64
- References
- 18
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 8 · 2023: 3 · 2022: 7 · 2021: 8 · 2020: 13 · 2019: 7 · 2018: 7 · 2017: 1
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endoscopy (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (15K00044)
- Topics
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
- Keywords
- intestinal metaplasia, gastric mucosa, magnifying narrow-band imaging, endoscopic diagnosis, diagnostic biomarkers, sensitivity and specificity, gastric cancer risk
- MeSH terms
- Aged, Biopsy, Cross-Sectional Studies, Female, Gastric Mucosa, Gastritis, Atrophic, Gastroscopy, Humans, Male, Metaplasia, Middle Aged, Biomarkers, Observer Variation, Helicobacter pylori, Helicobacter Infections, Disease Progression, Narrow Band Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Extending magnifying NBI diagnosis of intestinal metaplasia in the stomach: the white opaque substance marker. https://app.cochat.ai/papers/10.1055/s-0043-103409
- The paper
- Kanemitsu, T., Yao, K., Nagahama, T., Imamura, K., Fujiwara, S., Ueki, T., Chuman, K., Tanabe, H., Atsuko, O., Iwashita, A., Shimokawa, T., Uchita, K., & Kanesaka, T. (2017). Extending magnifying NBI diagnosis of intestinal metaplasia in the stomach: the white opaque substance marker. Endoscopy. https://doi.org/10.1055/s-0043-103409
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.